Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for

Jason E Ekert1, Kjell Johnson2, Brandy Strake1

  • 1Biologics Research, Biotechnology Center of Excellence, Janssen R&D, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania, United States of America.

Plos One
|March 19, 2014
PubMed

Insights

Three-dimensional (3D) spheroid cultures, unlike 2D monolayers, alter lung tumor cell responses to growth factors and targeted therapies, offering a more physiologically relevant model for cancer research.

Area of Science:

  • Oncology
  • Cell Biology
  • Biotechnology

Background:

  • Three-dimensional (3D) cell cultures, such as spheroids, are increasingly adopted for their ability to better replicate physiological tissue environments compared to traditional 2D monolayer cultures.
  • Understanding the biological and functional differences between 3D spheroids and 2D monolayers is crucial for advancing cancer research and drug development.

Purpose of the Study:

  • To characterize the phenotypic and functional disparities between lung tumor cells cultured as 3D spheroids versus 2D monolayers.
  • To compare epidermal growth factor receptor (EGFR) and cMET expression, phosphorylation, and signaling pathway activation in both culture models.

Main Methods:

  • Utilized eight lung tumor cell lines with varying EGFR and cMET expression to establish 3D spheroid models in low-attachment plates.
  • Assessed EGFR and cMET expression and phosphorylation via flow cytometry and MSD assay, respectively.
  • Evaluated cell proliferation, migration, and drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab, Onartuzumab) in both 2D and 3D cultures.

Main Results:

  • EGFR and cMET expression were reduced in untreated spheroid cultures by day four compared to monolayers.
  • Basal phosphorylation of EGFR and cMET was higher in spheroids, while ligand-stimulated phosphorylation was reduced compared to 2D cultures.
  • Spheroids exhibited altered proliferation responses to hepatocyte growth factor (HGF) and EGFR/cMET inhibitors, and demonstrated superior performance in cell migration assays.

Conclusions:

  • 3D spheroid culture significantly modifies lung tumor cell responses to growth factors and targeted therapies.
  • Spheroid models may provide a more accurate representation of the in vivo tumor microenvironment, impacting drug efficacy assessments.
  • These findings highlight the importance of considering 3D culture systems for preclinical drug screening and understanding tumor biology.